Michael Calviño-Suárez, Raquel Iglesias-Varela, Álvaro Lorenzo-Vizcaya, María Guzmán-Fernández, Beatriz Vasco-Varela, Fátima Salido-Toimil, Elsa López-Ansoar, Andrea Dorado-López, Manuel Rodríguez-López
{"title":"无抑制剂的重度或中度甲型血友病患者转用长半衰期 VIII 浓缩因子或非替代疗法:回顾性分析。加利西亚血栓与止血小组(G2TH-AGHH)的经验。","authors":"Michael Calviño-Suárez, Raquel Iglesias-Varela, Álvaro Lorenzo-Vizcaya, María Guzmán-Fernández, Beatriz Vasco-Varela, Fátima Salido-Toimil, Elsa López-Ansoar, Andrea Dorado-López, Manuel Rodríguez-López","doi":"10.24875/sangre.24000004","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":509342,"journal":{"name":"Revista Sangre","volume":"113 6","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cambio a concentrados de factor VIII de vida media prolongada o terapias no sustitutivas en pacientes con hemofilia A grave o moderada sin inhibidor: análisis retrospectivo. Experiencia del Grupo Gallego de Trombosis y Hemostasia (G2TH-AGHH)\",\"authors\":\"Michael Calviño-Suárez, Raquel Iglesias-Varela, Álvaro Lorenzo-Vizcaya, María Guzmán-Fernández, Beatriz Vasco-Varela, Fátima Salido-Toimil, Elsa López-Ansoar, Andrea Dorado-López, Manuel Rodríguez-López\",\"doi\":\"10.24875/sangre.24000004\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":509342,\"journal\":{\"name\":\"Revista Sangre\",\"volume\":\"113 6\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Sangre\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24875/sangre.24000004\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Sangre","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24875/sangre.24000004","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Cambio a concentrados de factor VIII de vida media prolongada o terapias no sustitutivas en pacientes con hemofilia A grave o moderada sin inhibidor: análisis retrospectivo. Experiencia del Grupo Gallego de Trombosis y Hemostasia (G2TH-AGHH)